Skip to main content
OpenTrials
Completed

NCT Number: NCT06040216

Evolution of EIFL Following PPV

Various classification systems have been described for epiretinal membrane (ERM). One of them is a new OCT-based staging scheme based on displacement and reorganization of inner retinal layers called ectopic inner retinal layers (EIFL). We evaluated pre-and perioperative factors related to time for evolution of EIFL.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Kocaeli University School of Medicine

Kocaeli, None Selected, 41001, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients undergoing idiopathic epiretinal membrane surgery

Exclusion criteria

  • Patients undergoing seconder epiretinal membrane surgery

Treatment and study plan

optical coherence tomography

Other

We observed the postoperative improvement in EIFL severity with optical coherence tomography

Primary outcomes

  1. Best corrected visual acuity

    Time frame: 1-month

    Best corrected visual acuity

Sponsors and collaborators

Lead sponsor

Kocaeli University

Other

Registry information

Official study title

Long-term Follow-up Results of Ectopic Inner Foveal Retinal Layers Evolution Following Pars Plana Vitrectomy

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Sep 15, 2023
Registry last updated
Sep 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.